NLRP3 and Bloom syndrome: Then we screened the mutation mentioned above by Sanger sequencing in a consecutive cohort of 30 treatment-naïve or active BS cases that fulfilled the 2014 ICBD criteria, which did not reveal NLRP3 p.Ala439Val mutation.